Medication Guide

In the pursuit of health and recovery, rational use of drugs is a crucial part. Patients should be fully aware of the information about the drug, including but not limited to efficacy, dosage, and contraindications, before using any drug. Be sure to follow the doctor's guidance and do not increase or decrease the dose or change the drug at will, so as not to affect the efficacy or cause adverse reactions; Be aware of drug-drug interactions and avoid self-medication.

Alectinib(Alecensa)

Alectinib treatment for non-small cell lung cancer.【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：205
Vibegron(Gemtesa‌)

Overactive bladder (OAB)【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：48
Ibrutinib(Imbruvica)

Ibrutinib for the treatment of Chronic Lymphatic Leukemia【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：242
Afatinib(Gilotrif)

Afatinib can be used to treat Non Small Cell Lung Cancer.【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：159
Trelagliptin(Zafatek)

Tragliptin is suitable for type 2 diabetes.【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：171
Fezolinetant(Veozah)

Fezolinetant is indicated for the treatment of vasomotor symptoms due to menopause.【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：304
Regorafenib(Stivarga)

STIVARGA is indicated for the treatment of patients with metastatic colorectal cancer (CRC).【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：229
Tofacitinib(Xeljanz)

Tofacitinib is indicated for the treatment of adult patients with rheumatoid arthritis.【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：249
Aprocitentan(Tryvio)

Used in combination with other antihypertensive drugs for the treatment of hypertension.【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：205
Axitinib(Inlyta)

Used for treating advanced renal cell carcinoma following failure of a prior systemic therapy.【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：250
Belzutifan(Welireg)

Applicable to von Hippel-Lindau (VHL) disease patients requiring treatment for renal cell carcinoma (RCC), central nervous system (CNS) hemangioblastoma, or pancreatic neuroendocri···【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：268
Capivasertib(Truqap)

Capivasertib is suitable for the treatment of adult patients with specific types of breast cancer.【more】
Article source：Captain MedicineRelease date：2026-01-05Recommended：201

home page previous 46 46/102 next last page

News

The U.S. FDA approved the combination of Pembrolizumab and Enfortumab vedotin-ejfv for the treatment
On November 21, 2025, the U.S. Food and Drug Administration (FDA) approved the regimen of pembrolizu···【more】

Recommended：[list:visits]2025-17-12
Lucius Pharmaceuticals Laos launched lorlatinib, a third-generation targeted drug for lung cancer
Lung cancer is the most rapidly increasing malignant tumor with the fastest increasing morbidity and···【more】

Recommended：[list:visits]2024-09-07
Lucius Pharmaceuticals Version of Vibegron Now Available
Lucius Pharmaceuticals Version of Vibegron Now Available1.Basic Drug InformationVibegron (generic na···【more】

Recommended：[list:visits]2026-06-08
Lao Pharmacies and Manufacturer Direct Shipping: Legal Pathways and Pitfall Guide for Overseas Medi
In recent years, leveraging the World Trade Organization (WTO) patent waiver for least-developed cou···【more】

Recommended：[list:visits]2026-05-08
How Can Chinese Patients Access Generic Drugs from Laos?
How Can Chinese Patients Access Generic Drugs from Laos?In recent years, generic drugs from Laos hav···【more】

Recommended：[list:visits]2026-04-08
Lucius Pharmaceuticals version of Ibrutinib is now available
Lucius Pharmaceuticals version of Ibrutinib is now availableIn a randomized controlled trial of 269 ···【more】

Recommended：[list:visits]2026-03-08
Laos Lucius, ASEAN Pharmaceuticals (TLPH), and Alliance Pharmaceuticals: Which generic drug manufac
Leveraging the WTO patent waiver for least-developed countries (extended to 2033), Laos has seen rap···【more】

Recommended：[list:visits]2026-31-07
Alectinib Has Been Launched in Laos
Alectinib Has Been Launched in LaosAlectinib is an oral targeted therapeutic drug belonging to the c···【more】

Recommended：[list:visits]2026-30-07

Lucius Pharmaceuticals

Lucius Pharmaceuticals (Lao) LTD. (Lucius Pharmaceuticals), with its manufacturing campus in Laos located in the capital city of Vientiane in 2020, officially begins its great journey to make effective and affordable medicines available to people in need around the world...More